Hurricane Sandy Exacerbates Propofol Shortage

APP Pharmaceuticals is facing delays on inbound shipments and product releases of proposal, exacerbating the shortage situation and creating some back-orders for ASCs, according to an ASCA report.

Advertisement

APP has told the FDA they are committed to resolving the distribution challenges as quickly as possible. The FDA is working with all propofol manufacturers to ensure propofol can reach the market as soon as possible.

Learn more about ASCA.

Related Articles on Anesthesia:
AcelRx to Seek Approval for Pain Controlling Drug Device
Marine Corps Looks for Small Rugged Anesthesia Machines
Equity Firm Industry Experts Team Up to Form US Anesthesia Partners

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Anesthesia

Advertisement

Comments are closed.